Ankle Swelling Algorithm

Safety

Red Flags — Rule Out Life-Threatening Causes First

Done

Act immediately if any red flag present — do not proceed to routine work-up.

Acute unilateral swelling + calf pain/warmth Tender, hot, asymmetric leg, recent travel/surgery/immobility → Same-day Wells score + D-dimer / proximal leg vein USS (NICE NG158)

Bilateral oedema + breathlessness PND, orthopnoea, raised JVP, bibasal crackles → Same-day Suspected heart failure → emergency assessment

Sudden severe leg swelling + collapse Haemodynamic instability, pale/mottled limb → 999 Phlegmasia cerulea dolens / ileofemoral DVT

Facial + ankle oedema + haematuria/proteinuria Periorbital puffiness, frothy urine → Same-day Nephrotic syndrome

Jaundice + ankle oedema + abdominal distension Stigmata of liver disease, ascites → Same-day Hepatic failure / decompensated cirrhosis

Oedema in pregnancy (from 20 weeks) or after the birth + raised BP or symptoms New BP ≥140/90, proteinuria, sudden swelling of face, hands or feet, severe headache, visual disturbance, epigastric/RUQ pain, vomiting, reduced fetal movements — symptoms even with a normal BP; BP ≥160/110 → Same-day maternity assessment Pre-eclampsia / HELLP — 999 if seizure, collapse or unstable

Unexplained unilateral swelling or lymphadenopathy Examine abdomen, pelvis, groin and nodes → Suspected cancer Consider suspected-cancer referral for unexplained lymphadenopathy or splenomegaly, especially with fever, night sweats, breathlessness, pruritus or weight loss (NICE NG12); otherwise image or refer by findings — do not label it malignant lymphoedema without evidence

Swelling + fever + erythema tracking Spreading cellulitis, lymphangitis, systemic sepsis → Same-day Admit if septic / diabetic

Missing a DVT in unilateral leg swelling risks fatal pulmonary embolism. New heart-failure presentations can deteriorate rapidly without diuresis. Unrecognised pre-eclampsia endangers mother and baby. Nephrotic syndrome requires rapid urine dipstick — proteinuria ++ or +++ with oedema mandates same-day review. Always check both legs simultaneously to detect asymmetry.

Diagnose

Characterise the Oedema — History & Pattern Recognition

Done

Determine whether oedema is pitting/non-pitting, unilateral/bilateral, and acute/chronic. Pattern drives diagnosis.

Onset & duration

Acute (<72h): DVT, cellulitis, trauma. Subacute (days–weeks): cardiac, renal. Chronic: venous insufficiency, lymphoedema, medications

Bilateral vs unilateral

Bilateral: systemic cause (cardiac, renal, hepatic, medication, hypoalbuminaemia). Unilateral: local cause (DVT, cellulitis, lymphoedema, chronic venous insufficiency)

Pitting vs non-pitting

Pitting: cardiac, renal, hepatic, venous, medications. Non-pitting: lymphoedema, myxoedema (hypothyroidism), lipoedema

Associated symptoms

Breathlessness (HF/PE), haematuria/frothy urine (renal), jaundice (hepatic), joint pain (inflammatory), skin changes (venous/lymphatic)

Medication review

Amlodipine/CCBs Common, NSAIDs, steroids, gabapentin/pregabalin, thiazolidinediones, oestrogen/HRT, minoxidil — all cause bilateral pitting oedema

Social history

Immobility, obesity, prolonged sitting (air travel, desk work), pregnancy, malnutrition (low albumin)

Risk factors & red-flag symptoms

Pain, erythema, warmth, fever; breathlessness, orthopnoea, PND, exercise tolerance; previous DVT, cancer, recent surgery, travel, immobility, pregnancy; rate of progression

Distribution

Ankle only: venous/gravity. Extends to thigh: systemic. Abdominal oedema + ascites: hepatic/cardiac. Face + ankles: nephrotic/allergic

Amlodipine and other calcium-channel blockers are the commonest drug cause of bilateral ankle oedema (venous insufficiency is the commonest cause overall) — always check the drug chart before extensive investigation. The pitting/non-pitting distinction is the single most useful examination finding: non-pitting oedema essentially rules out cardiac/renal/hepatic causes. Bilateral oedema with normal cardiac/renal/hepatic function in an ambulant patient is usually venous, dependent or drug-related; call it idiopathic only once these are excluded.

Diagnose

Classify the Underlying Cause

Done

Cardiac

Bilateral pitting, worse with exertion, orthopnoea, PND, raised JVP. HF with preserved or reduced EF. Check BNP/NT-proBNP

Venous insufficiency

Bilateral, worsens through day, improves overnight, varicosities, haemosiderin staining, lipodermatosclerosis. Commonest cause in elderly

DVT

Unilateral, acute, calf tenderness/warmth/erythema. Two-level Wells ≥2 = DVT likely. Requires formal exclusion

Renal

Periorbital morning oedema, marked proteinuria, hypoalbuminaemia and oedema together (albumin <25 g/L supports but does not diagnose), frothy urine. Check urine ACR/PCR, albumin, creatinine

Hepatic

Ascites + ankle oedema, low albumin, stigmata of liver disease, alcohol history. Check LFTs, albumin, coagulation

Lymphoedema

Dorsum of foot involved, non-pitting in later disease, skin thickening/hyperkeratosis, recurrent cellulitis, Stemmer sign supports (not absolute); history of malignancy/surgery/radiotherapy. Lipoedema spares the feet, bilateral and tender

Medication-induced

Bilateral pitting, onset after starting new drug (especially amlodipine), no systemic disease. Consider drug switch

Hypothyroidism

Non-pitting, generalised myxoedema, cold intolerance, weight gain, bradycardia. Check TSH (reflex FT4) if suspected (NG145)

Classification drives the treatment pathway completely — a diuretic that helps cardiac oedema can worsen lipoedema and does nothing for lymphoedema. Venous insufficiency is the most common cause of bilateral ankle swelling in the community, especially in older adults. A positive Stemmer sign supports lymphoedema but does not establish it alone. Hypothyroidism is often missed because oedema is non-pitting and TFTs are not routinely ordered.

Diagnose

Targeted Examination

Done

Vital signs

BP (hypertension → renal/cardiac), HR (AF → cardiac), RR (tachypnoea → HF/PE), temp (fever → cellulitis/DVT), SpO₂

Weight & BMI

Recent weight gain → fluid retention. Obesity → venous hypertension and dependency oedema. Compare to previous weights

Jugular venous pressure

Raised JVP → right heart failure, constrictive pericarditis, SVC obstruction

Heart sounds

S3 gallop, murmurs, displaced apex → cardiac cause. Check for pericardial friction rub

Chest auscultation

Bibasal crackles → pulmonary oedema (LVF). Pleural effusion → dullness to percussion

Abdominal exam

Hepatomegaly (HF/hepatic), ascites (shifting dullness → hepatic/cardiac), splenomegaly

Leg examination

Symmetry, pitting test (press 5 sec over tibia), skin changes (haemosiderin, liposclerosis, ulcers, varicosities), calf circumference if DVT suspected (calf tenderness counts only within the Wells criteria — do not use Homan's sign), pulses, capillary refill, temperature, sacral oedema if immobile

Stemmer's sign

Attempt to pinch dorsal foot skin: impossible = positive → supports lymphoedema; it does not establish or exclude it alone

Raised JVP with ankle oedema is a useful bedside pointer to heart failure. Serial weights help HF management — an individualised action plan can include a weight-gain trigger. Homan's sign has poor sensitivity/specificity for DVT and should not be used diagnostically.

Diagnose

Investigations — Targeted, Not Blanket

Done

All presentations

Observations, urinalysis (protein, blood) and medication review. Bloods guided by the picture: U&Es (systemic or renal disease, diuretics), albumin + LFTs (hepatic, nephrotic), FBC (anaemia, infection, malignancy), TSH (if thyroid features), urine ACR/PCR (proteinuria)

Suspected cardiac

NT-proBNP — <400 ng/L untreated: HF less likely but not excluded if suspicion remains (falsely low with obesity and on diuretics, ACEI/ARNI, beta-blockers, MRAs; raised by AF, renal, lung or liver disease, sepsis). 400–2000 ng/L: specialist assessment and echo within 6 weeks. >2000 ng/L: urgent referral, specialist assessment and echo within 2 weeks (NICE NG106). ECG, CXR

Suspected DVT

Two-level Wells (NICE NG158). Likely (≥2): proximal leg-vein USS within 4 h; if not possible, D-dimer then interim therapeutic anticoagulation and USS within 24 h; USS negative but D-dimer positive → stop interim anticoagulation, repeat USS at 6–8 days. Unlikely (≤1): quantitative D-dimer within 4 h (consider age-adjusted threshold over 50); negative → DVT unlikely; positive → USS within 4 h, or interim anticoagulation and USS within 24 h. Take FBC, renal and hepatic function, PT, APTT when starting interim anticoagulation — do not delay treatment for results; document bleeding risk, surgery, pregnancy, weight and interacting drugs

Suspected renal

Urine albumin:creatinine ratio (ACR), eGFR, serum albumin. Suspect nephrotic syndrome with marked proteinuria + hypoalbuminaemia + oedema; urgent renal assessment if severe hypoalbuminaemia, nephrotic-range proteinuria, AKI, haematuria, thrombosis or systemic illness

Suspected hepatic

LFTs, albumin, bilirubin, INR/PT (marker of synthetic function), USS abdomen (ascites, liver texture)

When NOT to investigate

Do NOT order extensive tests for bilateral ankle oedema if CCB started recently — trial of drug switch first. Do NOT order BNP if clear drug-induced cause identified — unless there is breathlessness or another heart-failure feature, which still needs NT-proBNP (NICE NG106)

NT-proBNP is the gatekeeper test for heart failure, but a low value does not exclude valvular disease, ischaemia or HF when suspicion remains. D-dimer is sensitive but non-specific, so it is most useful when DVT is unlikely on Wells. Test thyroid function when the history or examination suggests it.

Refer

Referral Criteria — When Primary Care Is Not Enough

Done

999

Haemodynamic instability, suspected massive PE, phlegmasia cerulea dolens, acute pulmonary oedema, severe hypoxaemia, collapse or shock, acute limb ischaemia

Same-day

Suspected DVT per the NG158 pathway, new symptomatic heart failure, suspected nephrotic syndrome (marked proteinuria + hypoalbuminaemia), decompensated liver disease, jaundice or new ascites

Suspected cancer · NICE NG12

Unexplained lymphadenopathy or splenomegaly (especially with fever, night sweats, breathlessness, pruritus or weight loss) → consider suspected-cancer referral. Unexplained unilateral swelling: examine abdomen, pelvis, groin and nodes — a mass follows its NG12 site pathway. DVT: assess for additional cancer symptoms/signs and investigate or refer if present (no routine extensive screening)

Cardiology / HF clinic

NT-proBNP >400: echo within 6 weeks. NT-proBNP >2000: urgent echo within 2 weeks (NICE NG106). Preserved EF heart failure → specialist confirmation

Nephrology

NICE NG203: KFRE 5-year risk >5%; sustained eGFR fall ≥25% with a category change, or ≥15 mL/min/1.73m², within 12 months; ACR ≥70 mg/mmol (unless known diabetes and appropriately treated); ACR >30 mg/mmol with persistent haematuria; hypertension poorly controlled on 4 or more drugs; known or suspected rare or genetic cause; suspected renal artery stenosis. eGFR <30 not known to nephrology: commonly used locally. Suspected nephrotic syndrome → same-day (see above)

Lymphoedema clinic

Confirmed or suspected lymphoedema → specialist compression and management. Diuretics do not treat lymphatic dysfunction — not routinely, unless a separate cardiac, renal or hepatic indication

Vascular surgery

Chronic venous insufficiency with non-healing venous leg ulcer, severe varicosities affecting quality of life, arterial disease found before compression (refer per local leg-ulcer pathway)

Primary care manage

CCB-induced oedema (switch drug), mild bilateral venous oedema with normal investigations, oedema of pregnancy (physiological) only once BP and urine protein are normal and there are no pre-eclampsia symptoms

The BNP/NT-proBNP pathway (NICE NG106) was designed specifically to streamline HF referral from primary care — using it correctly avoids both under-referral (missed HF) and over-referral (normal BNP). Diuretics do not treat lymphoedema and are used only for a separate indication. Assess arterial supply before moderate or strong compression — unrecognised PAD with compression can cause limb ischaemia; ABPI can be falsely high in diabetes or calcified arteries, where toe pressures or specialist assessment help.

Treat

Treatment Pathway — Cause-Specific Management

Done

Cardiac oedema (HF)

Loop diuretic First-line

Loop diuretic for congestion — starting dose by congestion, renal function, previous diuretic use, frailty and local HF protocol; lowest effective dose. Diuretics are not disease-modifying: optimise therapy via the HF pathway once phenotype is confirmed

DVT confirmed

DOAC anticoagulation Start same day

Rivaroxaban 15 mg BD for 21 days, then 20 mg OD (with food), or apixaban 10 mg BD for 7 days then 5 mg BD; at least 3 months. Before prescribing: Cockcroft–Gault CrCl (not eGFR), weight, FBC, renal and hepatic function, bleeding risk, pregnancy/breastfeeding, CYP3A4/P-gp interactions (local DOAC guidance). Specialist advice for CrCl <15, active cancer, antiphospholipid syndrome (triple-positive: DOACs unsuitable), significant hepatic disease, extreme weight, pregnancy (LMWH) or recurrence on anticoagulation

Medication-induced

Drug switch First step

Switch amlodipine to lercanidipine (lower oedema rate) or change CCB to ACEI/ARB/thiazide for BP management. Review all offending agents

Venous insufficiency

Compression hosiery First-line

Fitted graduated compression where arterial supply is adequate — check pulses and arterial risk; ABPI or toe pressure where indicated (diabetes, absent pulses, neuropathy, suspected PAD). Not in decompensated HF, acute DVT, acute ischaemia, severe PAD or severe cellulitis without assessment. Venous ulcers → leg-ulcer service (NWCSP)

Step 1Address reversible causes — stop/switch offending drugs, treat underlying infection, elevate limbs, reduce dietary salt if intake is high (no routine salt restriction in heart failure — NICE NG106)

Step 2Compression therapy — for venous oedema once arterial supply is assessed (ABPI >0.8 is a practical, not absolute, threshold for full compression). Bandaging for lymphoedema via specialist service

Step 3Diuretic therapy (cardiac/renal/hepatic congestion only) — loop diuretic, dose individualised per local protocol; titrate to clinical response at the lowest effective dose

Step 4Treat underlying cause — HF: confirm phenotype, then optimise via the HF pathway — for HFrEF, ACEI/ARNI/ARB + beta-blocker + MRA + SGLT2 inhibitor as tolerated (NICE NG106); SGLT2i ± MRA also in HFmrEF/HFpEF. Hypothyroid: levothyroxine (start 25–50 mcg OD if older or cardiac disease, otherwise about 1.6 mcg/kg/day; NICE NG145/CKS — check the SPC), titrated to TSH. Hepatic: specialist management

Step 5Refractory oedema — refer to the HF/renal specialist team; combination diuretics (e.g. metolazone) only under specialist guidance

Next steps: see Deep vein thrombosis · Heart failure · Cellulitis and erysipelas · Varicose veins · Peripheral arterial disease

Furosemide reduces hospitalisation in acute decompensated HF but does not improve mortality — disease-modifying therapy (ACEI/ARNI, beta-blocker, MRA, SGLT2 inhibitor) is what saves lives. Lercanidipine causes less oedema than amlodipine. Rivaroxaban and apixaban are first-line DOACs for DVT (NICE NG158) with no requirement for overlapping heparin. MRAs reduce mortality in HFrEF — part of foundational therapy, not a refractory-oedema add-on.

Lifestyle

Non-Pharmacological Interventions — Often More Effective Than Drugs

Done

Leg elevation Elevate legs above hip level for 30 min, 3× daily. At night, raise foot of bed by 15 cm. A simple, useful measure for venous oedema.

Salt restriction Adults: no more than 6 g salt/day (2.4 g sodium). In heart failure, NICE NG106 does not advise routine salt restriction — ask about intake and advise reducing it if high. Read food labels: processed foods are the main source.

Fluid restriction Not routine in heart failure (NICE NG106): restrict fluids only for dilutional hyponatraemia or high intake, and keep the need under review. Avoid excess water loading. Established HF: an individualised action plan may include a weight-gain trigger.

Exercise & mobilisation Calf muscle pump activation: foot dorsiflexion exercises 10 reps/hour when seated. Regular walking supports the calf pump.

Weight loss Weight management where appropriate — obesity causes dependency oedema independently of cardiac/renal causes. Support smoking cessation.

Compression hosiery adherence Worn from rising to bedtime — compliance is the main barrier. Ensure correct fitting (measure in morning before swelling). Consider donning aids for elderly patients.

Skin care Moisturise daily to prevent skin breakdown. Avoid trauma. Early treatment of fungal infections (tinea pedis) to prevent cellulitis entry point.

Alcohol reduction Alcohol causes both direct hypoalbuminaemia and hepatic disease. No more than 14 units a week, spread over 3 or more days (UK CMO); brief intervention in consultation.

Leg elevation lowers venous and capillary pressure in the legs. Evidence that salt restriction helps heart failure is limited, which is why NICE NG106 asks about intake rather than restricting it routinely. Tailor advice to mobility, frailty, cardiovascular status and cause. Compression non-adherence drives recurrent venous ulcers — education and practical aids (applicators, zip stockings) help. Skin breakdown in lymphoedema leads to recurrent cellulitis which further damages lymphatics — a vicious cycle broken by good skincare.

Safety

Follow-Up, Monitoring & Safety-Netting

Done

1 week

Check U&Es after starting or changing a diuretic where higher risk (congestion, renal impairment, frailty, ACEI/ARB/ARNI/MRA co-therapy) per local protocol. Assess diuresis response. Review compliance with compression. Recheck BP if hypertensive

2–4 weeks

Reassess oedema severity, weight change. If drug-induced oedema: confirm resolution after switch. Review investigation results (BNP, echo, USS)

3 months

Full review: classification confirmed, treatment effective? Step-up if inadequate response. HF: formal echocardiography result should be back

Ongoing (chronic)

Annual review for chronic venous insufficiency / lymphoedema / HF. Weight monitoring, medication review, skin assessment, compression renewal

Safety-net 999

Sudden severe breathlessness, chest pain, SpO₂ drops, collapse, acute severe unilateral leg pain/pallor (arterial ischaemia)

Safety-net same-day

Rapidly progressive swelling, new unilateral swelling with pain/warmth (DVT), new or worsening breathlessness or chest pain, fever or spreading erythema, jaundice or new ascites, severe proteinuria or haematuria, in pregnancy from 20 weeks or after the birth: sudden swelling of face, hands or feet, severe headache, visual disturbance, upper abdominal pain or vomiting (maternity unit), weight gain beyond the HF action-plan trigger

Diuretic monitoring

ACEI/ARNI/ARB/MRA (NG106): renal function and electrolytes before starting, 1–2 weeks after starting and after each dose increase, then every 3–6 months, sooner if the clinical picture changes. Use laboratory ranges; follow local renal/HF protocols for a significant creatinine rise, hyperkalaemia, hypotension or suspected AKI

Anticoagulation (DVT)

At least 3 months, then reassess provoking factor, recurrence and bleeding risk, and preference: consider stopping if a transient provoking factor has resolved; consider extended treatment after unprovoked or recurrent events if recurrence risk outweighs bleeding (NG158). Active cancer: 3–6 months then review. Assess for additional cancer symptoms or signs and investigate or refer if present (NG12 2026) — no routine extensive occult-cancer screening

Loop diuretics commonly cause hypokalaemia and renal changes — check U&Es early in higher-risk patients, particularly those on digoxin. 3-month DVT anticoagulation review is a critical safety checkpoint — extending unnecessarily increases major bleeding risk, but stopping too soon risks recurrence — balance the two for each patient. NICE advises against routine extensive cancer investigation after unprovoked DVT, but the 2026 NG12 update asks clinicians to assess for additional cancer symptoms or signs and investigate or refer if present. HF diuretic adjustments for weight gain should follow an individualised plan.

🦵 Ankle Swelling

Red Flags — Rule Out Life-Threatening Causes First

Characterise the Oedema — History & Pattern Recognition

Classify the Underlying Cause

Targeted Examination

Investigations — Targeted, Not Blanket

Referral Criteria — When Primary Care Is Not Enough

Treatment Pathway — Cause-Specific Management

Non-Pharmacological Interventions — Often More Effective Than Drugs

Follow-Up, Monitoring & Safety-Netting